句间停顿:
  • 1S
  • 3S
  • 5S
语速: x 1.0
  • 速度0.8X
  • 速度1.0X
  • 速度1.2X
  • 速度1.5X
  • 速度1.8X
  • 速度2X
始终显示原文
欢迎使用 KMF 精听精研
坚持练习精听,反复听、吃透每个句子,能够快速 提升听力能力
开始精听
或按 「 空格」开始播放

段落1

This is Scientific American 60-Second Science. I'm Cynthia Graber. This'll just take a minute.

点击显示原文

隐藏原文=

We like to think that medical equipment implanted in our bodies undergoes rigorous testing before it's put inside a person.

点击显示原文

隐藏原文=

That's not always the case, at least for cardiovascular devices.

点击显示原文

隐藏原文=

That's according to an article in the Journal of the American Medical Association.

点击显示原文

隐藏原文=

Researchers evaluated the FDA premarket approval process for 78 high-risk devices,

点击显示原文

隐藏原文=

such as pacemakers, stents and implanted defibrillators.

点击显示原文

隐藏原文=

They had assumed that these types of devices should and would be subject to random double-blinded studies with controls over an appropriate time-frame to investigate safety and efficacy.

点击显示原文

隐藏原文=

But for 51 of the devices--65 percent--approval was based on a single study.

点击显示原文

隐藏原文=

Only 27 percent of studies were randomized, and only 14 percent were blinded.

点击显示原文

隐藏原文=

Only half of the devices were compared with controls.

点击显示原文

隐藏原文=

The authors recognize the tension between sufficient testing and the need to get new drugs and devices to the public.

点击显示原文

隐藏原文=

But, they say, "The bar for evidence of benefit should be higher for devices because they are implanted and cannot simply be discontinued, as drugs can.

点击显示原文

隐藏原文=

In addition, although devices can be lifesaving, they also have great potential for risk and adverse events."

点击显示原文

隐藏原文=

Thanks for the minute, for Scientific American 60-Second Science. I'm Cynthia Graber.

点击显示原文

隐藏原文=
[ < 空格 > ]
当前句 /
/
  • 段落1
  • 第 1 句
  • 第 2 句
  • 第 3 句
  • 第 4 句
  • 第 5 句
  • 第 6 句
  • 第 7 句
  • 第 8 句
  • 第 9 句
  • 第 10 句
  • 第 11 句
  • 第 12 句
  • 第 13 句
  • 第 14 句

+ 创建收藏夹
保存 取消